scholarly journals A machine learning approach to precision medicine to determine optimal treatments for overweight and obese adults with knee osteoarthritis

2019 ◽  
Vol 27 ◽  
pp. S392-S393
Author(s):  
X. Jiang ◽  
A. Nelson ◽  
B. Cleveland ◽  
D. Beavers ◽  
T. Schwartz ◽  
...  
2021 ◽  
pp. 105447
Author(s):  
Gustavo Leporace ◽  
Felipe Gonzalez ◽  
Leonardo Metsavaht ◽  
Marcelo Motta ◽  
Felipe P. Carpes ◽  
...  

2019 ◽  
Vol 27 (7) ◽  
pp. 994-1001 ◽  
Author(s):  
A.E. Nelson ◽  
F. Fang ◽  
L. Arbeeva ◽  
R.J. Cleveland ◽  
T.A. Schwartz ◽  
...  

2017 ◽  
Vol 25 (12) ◽  
pp. 2014-2021 ◽  
Author(s):  
N. Lazzarini ◽  
J. Runhaar ◽  
A.C. Bay-Jensen ◽  
C.S. Thudium ◽  
S.M.A. Bierma-Zeinstra ◽  
...  

2018 ◽  
Vol 9 (1) ◽  
Author(s):  
Su-In Lee ◽  
Safiye Celik ◽  
Benjamin A. Logsdon ◽  
Scott M. Lundberg ◽  
Timothy J. Martins ◽  
...  

2020 ◽  
Author(s):  
Stefanie Warnat-Herresthal ◽  
Hartmut Schultze ◽  
Krishnaprasad Lingadahalli Shastry ◽  
Sathyanarayanan Manamohan ◽  
Saikat Mukherjee ◽  
...  

AbstractIdentification of patients with life-threatening diseases including leukemias or infections such as tuberculosis and COVID-19 is an important goal of precision medicine. We recently illustrated that leukemia patients are identified by machine learning (ML) based on their blood transcriptomes. However, there is an increasing divide between what is technically possible and what is allowed because of privacy legislation. To facilitate integration of any omics data from any data owner world-wide without violating privacy laws, we here introduce Swarm Learning (SL), a decentralized machine learning approach uniting edge computing, blockchain-based peer-to-peer networking and coordination as well as privacy protection without the need for a central coordinator thereby going beyond federated learning. Using more than 14,000 blood transcriptomes derived from over 100 individual studies with non-uniform distribution of cases and controls and significant study biases, we illustrate the feasibility of SL to develop disease classifiers based on distributed data for COVID-19, tuberculosis or leukemias that outperform those developed at individual sites. Still, SL completely protects local privacy regulations by design. We propose this approach to noticeably accelerate the introduction of precision medicine.


Sign in / Sign up

Export Citation Format

Share Document